虚拟护理可以减少儿科白血病的治疗负担吗? 一个回顾性成本分析
Jonas Dreher1, Andreas Meryk2, David Riedl1,3
1Department of Psychiatry, Psychotherapy, Psychosomatics and Medical Psychology, University Hospital of Psychiatry II, Medical University of Innsbruck, Innsbruck, Austria.
Pediatric blood & cancer
|June 19, 2023
概括
虚拟护理可以显著减少儿科白血病患者的治疗负担. 用视频咨询取代一半的面对面访问,可以减少旅行距离,时间和二氧化碳排放,特别是对于农村患者.
科学领域:
- 儿科瘤学 儿科瘤学
- 医疗保健服务研究 医疗服务研究
- 数字健康数字健康
背景情况:
- 患有白血病的儿童经常面临严重的治疗负担,包括长时间的旅行.
- 地理位置影响儿童癌症护理的旅行要求.
- 虚拟护理为减轻这些负担提供了一个潜在的解决方案.
研究的目的:
- 通过扩大虚拟护理,评估儿童白血病患者治疗负担的潜在降低.
- 量化虚拟护理对旅行距离,时间和环境排放的影响.
主要方法:
- 对152名儿科白血病患者的回顾性分析.
- 城市和农村患者群体之间的旅行指标的比较.
- 模拟50%的面对面访问被视频咨询所取代的影响.
主要成果:
- 农村患者旅行的距离远远 (中位数为7536公里),而不是城市患者 (中位数为1555公里).
- 通过视频咨询取代每次第二次访问,可以将农村患者的平均旅行距离减少3560公里.
- 这种转移还可以减少51个小时的旅行时间和623公斤的二氧化碳排放量.
结论:
- 虚拟护理的扩展为儿童白血病患者,特别是农村地区的儿童白血病患者减少治疗负担提供了巨大的机会.
- 实施虚拟护理策略可以大幅减少与旅行相关的成本,时间和环境影响.
- 远程医疗整合是一种可行的方法,可以提高儿科瘤护理的可访问性和可持续性.
相关概念视频
Cancer Therapies
7.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Methods of Documentation VI: Case Management Model
600
The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic...
For example, a patient with a chronic...
600
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
148
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
148
Cancer Survival Analysis
402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Combination Therapies and Personalized Medicine
5.0K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K


